ClinicalTrials.gov
public full text
Public Domain
Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors#325289
- Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL#881288
- A Combination of Rituximab and Varlilumab Immunotherapy in Patients with B-cell Lymphoma#321698
- Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma#140990
- EBNA1 destabilizes p21 to drive cell proliferation#1081802
Record · ID 435726
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive